Christopher K. Murray - Net Worth and Insider Trading
Christopher K. Murray Net Worth
The estimated net worth of Christopher K. Murray is at least $3 Million dollars as of 2024-11-05. Christopher K. Murray is the CHIEF TECHNICAL OPERATIONS of Blueprint Medicines Corp and owns about 33,853 shares of Blueprint Medicines Corp (BPMC) stock worth over $3 Million. Details can be seen in Christopher K. Murray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher K. Murray has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher K. Murray
Christopher K. Murray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher K. Murray owns 1 companies in total, including Blueprint Medicines Corp (BPMC) .
Click here to see the complete history of Christopher K. Murray’s form 4 insider trades.
Insider Ownership Summary of Christopher K. Murray
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BPMC | Blueprint Medicines Corp | 2024-03-07 | SVP & Technical Operations |
Christopher K. Murray Latest Holdings Summary
Christopher K. Murray currently owns a total of 1 stock. Christopher K. Murray owns 33,853 shares of Blueprint Medicines Corp (BPMC) as of March 7, 2024, with a value of $3 Million.
Latest Holdings of Christopher K. Murray
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BPMC | Blueprint Medicines Corp | 2024-03-07 | 33,853 | 96.55 | 3,268,507 |
Holding Weightings of Christopher K. Murray
Christopher K. Murray Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher K. Murray has made a total of 8 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 2,521 shares on March 7, 2024, which brought Christopher K. Murray around $228,629.
Insider Trading History of Christopher K. Murray
- 1
Christopher K. Murray Trading Performance
Christopher K. Murray Ownership Network
Ownership Network List of Christopher K. Murray
Ownership Network Relation of Christopher K. Murray
Christopher K. Murray Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Christopher K. Murray is the SVP & Technical Operations of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include President & R and D Fouad Namouni , director & CEO & President Jeffrey W. Albers , and Principal FAO Michael Landsittel .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Christopher K. Murray made 5 insider transaction in Blueprint Medicines Corp (BPMC) with a net sale of 9,342. Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 38,146 shares made by Michael Landsittel , and a net sale of 14,415 shares made by Ariel Hurley .
In summary, during the past 3 months, insiders sold 27,744 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 27,744 shares. During the past 18 months, 464,866 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 464,866 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Christopher K. Murray Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher K. Murray. You might contact Christopher K. Murray via mailing address: C/o Blueprint Medicines Corporation, 38 Sidney Street, Suite 200, Cambridge Ma 02139.